According to the research report, the global vascular grafts market size is expected to touch USD 8.5 Billion by 2030, from USD 5.65 Billion in 2022, growing with a significant CAGR of 5.24% from 2022 to 2030.
The vascular grafts report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global vascular grafts in conjunction
with the geographical landscape of this vertical have also been included in
this report.
The report offers intricate dynamics about
different aspects of the global vascular grafts market, which aids companies
operating in the market in making strategic development decisions. The study
also elaborates on significant changes that are highly anticipated to configure
growth of the global vascular grafts during the forecast period. It also
includes a key indicator assessment that highlights growth prospects of this
market and estimates statistics related to growth of the market in terms of
value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1758
| Report Coverage | Details |
| Market Size by 2030 | USD 8.5 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.24% |
| North America Market Share in 2021 | 31% |
| Endovascular Stent Grafts Market Share in 2021 | 64% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, End User, Raw Material, Geography |
This study covers a detailed segmentation
of the global vascular grafts market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global vascular grafts market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- Getinge AB
- Medtronic PLC
- LeMaitre vascular Inc
- WL gore and associates
- terumo corporation
- Shanghai suokang medical implants Co limited
- Cook medical
Market Segmentation
- Vascular Grafts for Aorta Disease
- Peripheral Vascular Grafts
- Endovascular Stent Grafts
- Coronary Artery By-Pass Grafts
By Application
- Cardiac Aneurysm
- Kidney Failure
- Vascular Occlusion
- Coronary Artery Disease
By Raw Material
- Polyester Vascular Grafts
- Polytetrafluoroethylene Vascular Grafts
- Polyurethane Vascular Grafts
- Biological Material Based Vascular Grafts
- Human Saphenous and Umbilical Veins
- Tissue Engineered Materials
By End User
- Hospitals
- Ambulatory Surgical Centers
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global vascular grafts report is based on detailed
primary as well as secondary research. With the help of in-depth insights of
the market-affiliated information that is obtained and legitimated by
market-admissible resources, analysts have offered riveting observations and authentic
forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global vascular grafts market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Vascular Grafts Market
5.1. COVID-19 Landscape: Vascular Grafts Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Vascular Grafts Market, By Product
8.1. Vascular Grafts Market, by Product Type, 2022-2030
8.1.1. Vascular Grafts for Aorta Disease
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Peripheral Vascular Grafts
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Endovascular Stent Grafts
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Coronary Artery By-Pass Grafts
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Vascular Grafts Market, By End Use
9.1. Vascular Grafts Market, by End Use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Vascular Grafts Market, By Application Type
10.1. Vascular Grafts Market, by Application Type, 2022-2030
10.1.1. Cardiac Aneurysm
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Kidney Failure
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Vascular Occlusion
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Coronary Artery Disease
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Vascular Grafts Market, By Raw Material Type
11.1. Vascular Grafts Market, by Raw Material Type, 2022-2030
11.1.1. Polyester Vascular Grafts
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Polytetrafluoroethylene Vascular Grafts
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Polyurethane Vascular Grafts
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Biological Material Based Vascular Grafts
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Human Saphenous and Umbilical Veins
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Tissue Engineered Materials
11.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Vascular Grafts Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
Chapter 13. Company Profiles
13.1. Getinge AB
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Medtronic PLC
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. LeMaitre vascular Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. WL gore and associates
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. terumo corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Shanghai suokang medical implants Co limited
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Cook Medical
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments